Enterohaemorrhagic E. coli utilizes host- and microbiota-derived L-malate as a signaling molecule for intestinal colonization.
Bin LiuLingyan JiangYutao LiuHongmin SunJun YanChenbo KangBin YangPublished in: Nature communications (2023)
The mammalian gastrointestinal tract is a complex environment that hosts a diverse microbial community. To establish infection, bacterial pathogens must be able to compete with the indigenous microbiota for nutrients, as well as sense the host environment and modulate the expression of genes essential for colonization and virulence. Here, we found that enterohemorrhagic Escherichia coli (EHEC) O157:H7 imports host- and microbiota-derived L-malate using the DcuABC transporters and converts these substrates into fumarate to fuel anaerobic fumarate respiration during infection, thereby promoting its colonization of the host intestine. Moreover, L-malate is important not only for nutrient metabolism but also as a signaling molecule that activates virulence gene expression in EHEC O157:H7. The complete virulence-regulating pathway was elucidated; the DcuS/DcuR two-component system senses high L-malate levels and transduces the signal to the master virulence regulator Ler, which in turn activates locus of enterocyte effacement (LEE) genes to promote EHEC O157:H7 adherence to epithelial cells of the large intestine. Disruption of this virulence-regulating pathway by deleting either dcuS or dcuR significantly reduced colonization by EHEC O157:H7 in the infant rabbit intestinal tract; therefore, targeting these genes and altering physiological aspects of the intestinal environment may offer alternatives for EHEC infection treatment.
Keyphrases
- escherichia coli
- microbial community
- antimicrobial resistance
- biofilm formation
- pseudomonas aeruginosa
- staphylococcus aureus
- gene expression
- genome wide
- klebsiella pneumoniae
- antibiotic resistance genes
- genome wide identification
- poor prognosis
- cystic fibrosis
- heavy metals
- wastewater treatment
- type diabetes
- transcription factor
- cancer therapy
- long non coding rna
- multidrug resistant
- drug delivery
- candida albicans
- metabolic syndrome
- risk assessment